IP Verse

Long Germline Dh Genes And Long Hcdr3 Antibodies - EP3476942

The patent EP3476942 was granted to Trianni on Jan 26, 2022. The application was originally filed on Oct 27, 2017 under application number EP17198800A. The patent is currently recorded with a legal status of "Revoked".

EP3476942

TRIANNI
Application Number
EP17198800A
Filing Date
Oct 27, 2017
Status
Revoked
Mar 14, 2025
Grant Date
Jan 26, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

REGENERON PHARMACEUTICALSOct 25, 2022J A KEMPADMISSIBLE

Patent Citations (27) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2013219535
DESCRIPTIONUS5591669
DESCRIPTIONUS5593598
DESCRIPTIONUS5612205
DESCRIPTIONUS5661016
DESCRIPTIONUS5789650
DESCRIPTIONUS5814318
DESCRIPTIONUS5874299
DESCRIPTIONUS5877397
DESCRIPTIONUS6023010
DESCRIPTIONUS6091001
DESCRIPTIONUS6130364
DESCRIPTIONUS6162963
DESCRIPTIONUS6570061
DESCRIPTIONUS6596541
DESCRIPTIONUS6673986
DESCRIPTIONUS7041871
DESCRIPTIONUS7064244
DESCRIPTIONUS7145056
DESCRIPTIONWO2017035252
EXAMINATIONWO2011158009
EXAMINATIONWO2013041844
OPPOSITIONUS2013219535
OPPOSITIONWO2011158009
OPPOSITIONWO2021003152
OTHERUS2013219535
OTHERWO2011158009

Non-Patent Literature (NPL) Citations (43) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ARAKI, Nucleic Acids Res., (19970000), vol. 25, pages 868 - 72
DESCRIPTION- BAER; BODE, Curr Opin Biotechnol, (20010000), vol. 12, pages 473 - 80
DESCRIPTION- BASSING et al., Cell, (20020000), vol. 109, no. S45
DESCRIPTION- BOLE et al., J Cell Biol., (19860000), vol. 102, page 1558
DESCRIPTION- BRINEY et al., Immunology, (20120000), vol. 137, pages 56 - 64
DESCRIPTION- BRODEUR et al., Monoclonal Antibody Production Techniques and Applications, Marcel Dekker, Inc., (19870000), pages 51 - 63
DESCRIPTION- DE VREE et al., Nature Biotechnology, (20140000), vol. 32, pages 1019 - 1025
DESCRIPTION- HAAS; WABL, Nature, (19830000), vol. 306, pages 387 - 9
DESCRIPTION- HE et al., Nuc. Acids Res., (20160000), vol. 44, page e85
DESCRIPTION- HOESS et al., Nucleic Acids Res., (19860000), vol. 14, pages 2287 - 00
DESCRIPTION- KOHLER et al., Nature, (19750000), vol. 256, pages 495 - 497
DESCRIPTION- KOZBOR, J. Immunol., (19840000), vol. 133, page 3001
DESCRIPTION- LANGER et al., Nucleic Acids Res., (20020000), vol. 30, pages 3067 - 77
DESCRIPTION- LEE; SADOWSKI, Prog Nucleic Acid Res Mol Biol., (20050000), vol. 80, pages 1 - 42
DESCRIPTION- LEE; SAITO, Gene, (19980000), vol. 216, pages 55 - 65
DESCRIPTION- LEFRANC et al., Nucleic Acids Res., (19990000), vol. 27, pages 209 - 212
DESCRIPTION- PADLAN, Mol. Immunol., (19940000), vol. 31, page 169
DESCRIPTION- PLoS ONE, (20120000), vol. 7, page e36750
DESCRIPTION- Proc Natl Acad Sci USA., (19850100), vol. 82, no. 2, pages 488 - 92
DESCRIPTION- SAMBROOK et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, (19890000), vol. 1 -3
DESCRIPTION- SELA-CULANG et al., Front. Immunol., (20130000), vol. 4, page 302
DESCRIPTION- TONEGAWA, Nature, (19830000), vol. 302, pages 575 - 81
DESCRIPTION- WANG et al., Cell, (20130000), vol. 153, page 1379
DESCRIPTION- WEINER MP; COSTA GL; SCHOETTLIN W; CLINE J; MATHUR E; BAUER JC, "Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction", Gene, (19941230), vol. 151, no. 1-2, doi:doi:10.1016/0378-1119(94)90641-6, pages 119 - 23, XP023541818
DESCRIPTION- CHENNA R; SUGAWARA H; KOIKE T; LOPEZ R; GIBSON TJ; HIGGINS DG; THOMPSON. JD, "Multiple sequence alignment with the Clustal series of programs", Nucleic Acids Res., (20030000), vol. 31, doi:doi:10.1093/nar/gkg500, pages 3497 - 3500, XP002316493
EXAMINATION- TUAILLON N & CAPRA J D ED - TUAILLON N & CAPRA J D, "VHD rearrangements in human immunoglobulin heavy chain minilocus transgenic mice", EUR. J. IMMUNOL,, (20000101), vol. 30, doi:10.1002/1521-4141(200010)30:10<2998::AID-IMMU2998>3.0.CO;2-X, pages 2998 - 3005, XP002794629
EXAMINATION- ZEMLIN M ET AL, "Expressed Murine and Human CDR-H3 Intervals of Equal Length Exhibit Distinct Repertoires that Differ in their Amino Acid Composition and Predicted Range of Structures", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, (20031205), vol. 334, no. 4, doi:10.1016/J.JMB.2003.10.007, ISSN 0022-2836, pages 733 - 749, XP004473368
EXAMINATION- Bryan S. Briney ET AL, "Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire", Immunology, GB, (20120802), vol. 137, no. 1, doi:10.1111/j.1365-2567.2012.03605.x, ISSN 0019-2805, pages 56 - 64, XP055712301
OPPOSITION- Lefranc Marie-Paule, Lefranc Gerard, "THE IMMUNOGLOBULIN FactsBook", (20010101), XP055978710
OPPOSITION- Murphy K, Et Al., "JANEWAY'S IMMUNOBIOLOGY 9th Edition", (20160101), XP055978709
OPPOSITION- TUAILLON et al., "VHD rearrangements in human immunoglobulin heavy chain minilocus transgenic mice", Eur J Immunol, (20000000), vol. 30, doi:10.1002/1521-4141(200010)30:10<2998::AID-IMMU2998>3.0.CO;2-X, pages 2998 - 3005, XP071219744
OPPOSITION- ZEMLIN et al., "Expressed Murine and Human CDR-H3 Intervals of Equal Length Exhibit Distinct Repertoires that Differ in their Amino Acid Composition and Predicted Range of Structures", J Mol Biol, (20030000), vol. 334, doi:10.1016/j.jmb.2003.10.007, pages 733 - 749, XP004473368
OPPOSITION- BRINEY et al., "Frequency and genetic characterization of V (DD) J recombinants in the human peripheral blood antibody repertoire", Immunology, (20120000), vol. 137, doi:10.1111/j.1365-2567.2012.03605.x, pages 56 - 64, XP055712301
OTHER- "Chapter 5: The generation of Lymphocyte antigen receptors", MURPHY WEAVER, Janeway's Immunobiology, Garland Science, (20160000), pages 173 - 212, XP055782753
OTHER- TUAILLON, CAPRA, "VhD rearrangements in human immunoglobulin heavy chain minilocus transgenic mice", Eur J Immunol, (20000000), vol. 30, doi:10.1002/1521-4141(200010)30:10<2998::AID-IMMU2998>3.0.CO;2-X, pages 2998 - 3005, XP002794629
OTHER- ZEMLIN et al., "Expressed Murine and Human CDR-H3 Intervals of Equal Length Exhibit Distinct Repertoires that Differ in their Amino Acid Composition and Predicted Range of Structures", J Mol Biol, (20030000), vol. 334, doi:10.1016/j.jmb.2003.10.007, pages 733 - 749, XP004473368
OTHER- BRINEY et al., "Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire", Immunology, (20120000), vol. 137, pages 56 - 64, XP055712301
SEARCH- FENG WANG ET AL, "Reshaping Antibody Diversity", CELL, (20130601), vol. 153, no. 6, doi:10.1016/j.cell.2013.04.049, ISSN 0092-8674, pages 1379 - 1393, XP055169986 [X] 15 * page 5; figure 1; figure 4 * [Y] 5
SEARCH- MUYLDERMANS SERGE ET AL, "Distinct antibody species: structural differences creating therapeutic opportunities", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, (20160227), vol. 40, doi:10.1016/J.COI.2016.02.003, ISSN 0952-7915, pages 7 - 13, XP029551342 [Y] 1-15 * page 6, first full paragraph *
SEARCH- YONG ZHANG ET AL, "An Antibody CDR3-Erythropoietin Fusion Protein", ACS CHEMICAL BIOLOGY, (20131018), vol. 8, no. 10, doi:10.1021/cb4004749, ISSN 1554-8929, pages 2117 - 2121, XP055215669 [X] 1-4,6,8-10,12-13 * abstract; page 2119; "Methods" *
SEARCH- TAO LIU ET AL, "Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists", PROCEEDINGS NATIONAL ACADEMY OF SCIENCES PNAS, US, (20150120), vol. 112, no. 5, doi:10.1073/pnas.1423668112, ISSN 0027-8424, pages 1356 - 1361, XP055340709 [X] 1-4,6,8-10,12-13 * page 1357, column 2; page 1360, "Materials and methods" * [Y] 5,7,11,14
SEARCH- DAVID EASTERHOFF ET AL, "Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial", PLOS PATHOGENS, (20170224), vol. 13, no. 2, doi:10.1371/journal.ppat.1006182, page e1006182, XP055440478 [Y] 1-15 * page 3 *
SEARCH- LEI YU ET AL, "Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1", FRONTIERS IN IMMUNOLOGY, (20140602), vol. 5, doi:10.3389/fimmu.2014.00250, XP055440470 [Y] 7,11,14 * pages 4-5 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents